UI Hospitals and Clinics

Clinical Trial Details

Short Title
Official Title
A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement Therapy: A Harmonized Protocol Across Sponsors

The purpose of this research study is to determine the number of patients affected by Fibrosing Colonapathy in people with cystic fibrosis and to learn more about what might cause it, including use of pancreatic enzyme supplements. 

Start Date
February 22, 2013
End Date
August 22, 2023
Gender Preference
Age Group
0 - 99 years
Principal Investigator
Richard Ahrens, MD
Contact Info

Mary Teresi, PharmD  mary-teresi@uiowa.edu

Cystic Fibrosis ; Fibrosing Colonapathy ;

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.